ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation

FRA:ABL • US0028241000

Current stock price

79.4 EUR
+1.28 (+1.64%)
Last:

This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ABL.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ABL was profitable.
  • In the past year ABL had a positive cash flow from operations.
  • In the past 5 years ABL has always been profitable.
  • In the past 5 years ABL always reported a positive cash flow from operatings.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.52%, ABL belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 12.51%, ABL belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
  • ABL has a better Return On Invested Capital (9.14%) than 79.31% of its industry peers.
  • ABL had an Average Return On Invested Capital over the past 3 years of 8.63%. This is in line with the industry average of 9.41%.
  • The 3 year average ROIC (8.63%) for ABL is below the current ROIC(9.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROIC 9.14%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 14.72%, ABL belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ABL has grown nicely.
  • ABL's Operating Margin of 18.78% is fine compared to the rest of the industry. ABL outperforms 79.31% of its industry peers.
  • ABL's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 56.66%, ABL perfoms like the industry average, outperforming 53.45% of the companies in the same industry.
  • ABL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.78%
PM (TTM) 14.72%
GM 56.66%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ABL.DE Health Analysis

2.1 Basic Checks

  • ABL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ABL has been increased compared to 1 year ago.
  • The number of shares outstanding for ABL has been reduced compared to 5 years ago.
  • Compared to 1 year ago, ABL has an improved debt to assets ratio.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • ABL has an Altman-Z score of 4.52. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
  • ABL's Altman-Z score of 4.52 is fine compared to the rest of the industry. ABL outperforms 79.31% of its industry peers.
  • ABL has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
  • ABL's Debt to FCF ratio of 1.75 is amongst the best of the industry. ABL outperforms 81.03% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that ABL is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.19, ABL is in the better half of the industry, outperforming 70.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Altman-Z 4.52
ROIC/WACC1.08
WACC8.43%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that ABL should not have too much problems paying its short term obligations.
  • ABL's Current ratio of 1.58 is in line compared to the rest of the industry. ABL outperforms 44.83% of its industry peers.
  • ABL has a Quick Ratio of 1.18. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
  • ABL has a Quick ratio of 1.18. This is comparable to the rest of the industry: ABL outperforms 44.83% of its industry peers.
  • The current and quick ratio evaluation for ABL is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.18
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ABL.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 9.00% over the past year.
  • Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 6.59% in the last year.
  • The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)9%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%5.5%
Revenue 1Y (TTM)6.59%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%7.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.74% on average over the next years. This is quite good.
  • ABL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.42% yearly.
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y9.74%
Revenue Next Year8.79%
Revenue Next 2Y8.44%
Revenue Next 3Y7.93%
Revenue Next 5Y8.42%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. ABL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.84, which indicates a rather expensive current valuation of ABL.
  • Compared to the rest of the industry, the Price/Earnings ratio of ABL indicates a rather cheap valuation: ABL is cheaper than 82.76% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of ABL to the average of the S&P500 Index (27.35), we can say ABL is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 14.80 indicates a correct valuation of ABL.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 72.41% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.23. ABL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.84
Fwd PE 14.8
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ABL's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 72.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.85
EV/EBITDA 14.21
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • ABL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.66
PEG (5Y)2.5
EPS Next 2Y10.46%
EPS Next 3Y10.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ABL.DE Dividend Analysis

5.1 Amount

  • ABL has a Yearly Dividend Yield of 2.72%. Purely for dividend investing, there may be better candidates out there.
  • ABL's Dividend Yield is rather good when compared to the industry average which is at 1.30. ABL pays more dividend than 81.03% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ABL pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.72%

5.2 History

  • The dividend of ABL is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years7
Div Non Decr Years7
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 63.09% of the earnings are spent on dividend by ABL. This is not a sustainable payout ratio.
  • The dividend of ABL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP63.09%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABL.DE Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

FRA:ABL (4/27/2026, 7:00:00 PM)

79.4

+1.28 (+1.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-16
Earnings (Next)07-15
Inst Owners81.92%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap137.97B
Revenue(TTM)45.13B
Net Income(TTM)6.52B
Analysts80.57
Price Target113.78 (43.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.72%
Yearly Dividend2.03
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)-0.41%
PT rev (3m)-9.11%
EPS NQ rev (1m)-0.38%
EPS NQ rev (3m)-1.03%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-0.56%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)1.7%
Revenue NY rev (3m)1.5%
Valuation
Industry RankSector Rank
PE 17.84
Fwd PE 14.8
P/S 3.65
P/FCF 21.85
P/OCF 16.89
P/B 3.1
P/tB 7.16
EV/EBITDA 14.21
EPS(TTM)4.45
EY5.6%
EPS(NY)5.36
Fwd EY6.76%
FCF(TTM)3.63
FCFY4.58%
OCF(TTM)4.7
OCFY5.92%
SpS21.78
BVpS25.61
TBVpS11.09
PEG (NY)1.66
PEG (5Y)2.5
Graham Number50.6426 (-36.22%)
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROCE 11.86%
ROIC 9.14%
ROICexc 10.47%
ROICexgc 20.23%
OM 18.78%
PM (TTM) 14.72%
GM 56.66%
FCFM 16.68%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Debt/EBITDA 0.86
Cap/Depr 69.67%
Cap/Sales 4.9%
Interest Coverage 15.28
Cash Conversion 83.6%
Profit Quality 113.35%
Current Ratio 1.58
Quick Ratio 1.18
Altman-Z 4.52
F-Score6
WACC8.43%
ROIC/WACC1.08
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)9%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%5.5%
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y9.74%
Revenue 1Y (TTM)6.59%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%7.78%
Revenue Next Year8.79%
Revenue Next 2Y8.44%
Revenue Next 3Y7.93%
Revenue Next 5Y8.42%
EBIT growth 1Y18.35%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year26.44%
EBIT Next 3Y14.4%
EBIT Next 5Y12.26%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%

ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ

What is the fundamental rating for ABL stock?

ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.


Can you provide the valuation status for ABBOTT LABORATORIES?

ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.


How profitable is ABBOTT LABORATORIES (ABL.DE) stock?

ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.


What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?

The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 8 / 10.


Is the dividend of ABBOTT LABORATORIES sustainable?

The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 63.09%.